Immune checkpoint inhibitors (ICIs) improve clinical outcomes in patients suffering from
different types of cancer. Liver toxicity is one of the immune-related adverse events …

Cancer immunotherapy, which leverages features of the immune system to target neoplastic
cells, has revolutionized the treatment of cancer. The use of these therapies has rapidly …

There are currently more than 1000 prescription medications available for use in the United
States and more than 100,000 over-the-counter herbal and dietary supplements (HDS) …

The advent of immune checkpoint inhibitors (ICIs) caused a paradigm shift both in drug
development and clinical practice; however, by virtue of their mechanism of action, the …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumor in the world
and its incidence is increasing in many countries. In recent years, with the deepening …

Immune checkpoint blockade (ICB) therapy has been considered as an effective way to
boost immune cells to recognize and attack tumors. However, side effects known as immune …

Immune checkpoint blockade (ICB) therapy for cancer has achieved great success both in
clinical results and on the market. At the same time, success drives more attention from …

Cancer immunotherapies have generated some miracles in the clinic by orchestrating our
immune system to combat cancer cells. However, the safety and efficacy concerns of the …

Introduction: Immune checkpoint inhibitors (ICIs) are recommended for various types of
cancer. On the other hand, these ICIs may cause immune-related adverse events (irAEs) …

ICI-related hepatotoxicity (IRH) is becoming more and more common as immune checkpoint
inhibitors (ICIs) have begun to be increasingly approved and used in combination with other …